Chenguang Biotech Group Cash Flow Conversion Efficiency
Chenguang Biotech Group cash flow conversion efficiency. Based on the latest financial reports, Chenguang Biotech Group (300138) has a cash flow conversion efficiency ratio of 0.155x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥524.96 Million ≈ $76.82 Million USD) by net assets (CN¥3.39 Billion ≈ $495.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Chenguang Biotech Group (2007–2025)
Cash flow conversion efficiency of Chenguang Biotech Group from 2007 to 2025. This chart illustrates how Chenguang Biotech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Chenguang Biotech Group stock price for real-time trading data and today's change.
Chenguang Biotech Group Cash Flow Conversion Ratio Explained
Chenguang Biotech Group cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Chenguang Biotech Group Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chenguang Biotech Group ranked by their cash flow conversion efficiency. Also see 300138 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangxi Guotai Civilian
SHG:603977
|
-0.035x |
|
Irish Continental Group PLC
IR:IR5B
|
0.070x |
|
Aktia Bank Abp
HE:AKTIA
|
-0.058x |
|
Empire State Realty Trust Inc
NYSE:ESRT
|
0.059x |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
N/A |
|
Sparebanken Sor
OL:SOR
|
0.095x |
|
Hunan Er Kang Pharmaceutical
SHE:300267
|
0.040x |
|
Guangxi Radio and Television Information Network Corp Ltd
SHG:600936
|
-0.203x |
Annual Cash Flow Conversion Efficiency for Chenguang Biotech Group (2007–2025)
The table below shows the annual cash flow conversion efficiency of Chenguang Biotech Group from 2007 to 2025. Review Chenguang Biotech Group (300138) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.44 Billion ≈ $503.23 Million |
CN¥212.91 Million ≈ $31.15 Million |
0.062x | +187.65% |
| 2024-12-31 | CN¥3.15 Billion ≈ $461.63 Million |
CN¥-222.81 Million ≈ $-32.60 Million |
-0.071x | +51.17% |
| 2023-12-31 | CN¥3.53 Billion ≈ $516.88 Million |
CN¥-510.91 Million ≈ $-74.76 Million |
-0.145x | -163.27% |
| 2022-12-31 | CN¥3.21 Billion ≈ $470.32 Million |
CN¥734.81 Million ≈ $107.53 Million |
0.229x | +895.84% |
| 2021-12-31 | CN¥2.78 Billion ≈ $407.30 Million |
CN¥63.90 Million ≈ $9.35 Million |
0.023x | -91.07% |
| 2020-12-31 | CN¥2.06 Billion ≈ $301.37 Million |
CN¥529.41 Million ≈ $77.47 Million |
0.257x | +1938.29% |
| 2019-12-31 | CN¥1.74 Billion ≈ $254.77 Million |
CN¥-24.35 Million ≈ $-3.56 Million |
-0.014x | +56.69% |
| 2018-12-31 | CN¥1.74 Billion ≈ $254.64 Million |
CN¥-56.18 Million ≈ $-8.22 Million |
-0.032x | +64.08% |
| 2017-12-31 | CN¥1.62 Billion ≈ $237.63 Million |
CN¥-145.95 Million ≈ $-21.36 Million |
-0.090x | +57.39% |
| 2016-12-31 | CN¥1.52 Billion ≈ $223.15 Million |
CN¥-321.62 Million ≈ $-47.06 Million |
-0.211x | -365.52% |
| 2015-12-31 | CN¥1.43 Billion ≈ $208.84 Million |
CN¥-64.66 Million ≈ $-9.46 Million |
-0.045x | -116.74% |
| 2014-12-31 | CN¥1.01 Billion ≈ $147.58 Million |
CN¥272.96 Million ≈ $39.94 Million |
0.271x | +835.08% |
| 2013-12-31 | CN¥990.39 Million ≈ $144.93 Million |
CN¥-36.47 Million ≈ $-5.34 Million |
-0.037x | +74.15% |
| 2012-12-31 | CN¥997.86 Million ≈ $146.02 Million |
CN¥-142.11 Million ≈ $-20.79 Million |
-0.142x | -267.87% |
| 2011-12-31 | CN¥968.71 Million ≈ $141.75 Million |
CN¥82.18 Million ≈ $12.03 Million |
0.085x | +141.55% |
| 2010-12-31 | CN¥933.05 Million ≈ $136.53 Million |
CN¥-190.51 Million ≈ $-27.88 Million |
-0.204x | -257.95% |
| 2009-12-31 | CN¥210.67 Million ≈ $30.83 Million |
CN¥27.23 Million ≈ $3.99 Million |
0.129x | +111.04% |
| 2008-12-31 | CN¥147.93 Million ≈ $21.65 Million |
CN¥9.06 Million ≈ $1.33 Million |
0.061x | +127.06% |
| 2007-12-31 | CN¥101.70 Million ≈ $14.88 Million |
CN¥-23.02 Million ≈ $-3.37 Million |
-0.226x | -- |
About Chenguang Biotech Group
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more